REGINE GERVAIS: Open Payments
NPI 1871941286 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$570 in 25 payments from 15 companies in 2025. Trend: 2023 $842 · 2024 $752 · 2025 $570
Food & beverage: $570
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 3 | $82 |
| PFIZER INC. | 3 | $79 |
| Actelion Pharmaceuticals US, Inc. | 2 | $60 |
| Merck Sharp & Dohme LLC | 3 | $57 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $52 |
| ABIOMED | 2 | $40 |
| CVRx, Inc. | 2 | $30 |
| Novo Nordisk Inc | 1 | $28 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $26 |
| Abbott Laboratories | 1 | $24 |
Products named: LEQVIO, ELIQUIS, UPTRAVI, VERQUVO, Barostim Neo System, Ozempic, VYNDAQEL, Kerendia.
Industry payments across FL — which companies pay providers there.
